Quantum-Si incorporated (NASDAQ:QSI - Free Report) - Analysts at HC Wainwright reduced their Q2 2025 earnings per share estimates for shares of Quantum-Si in a report released on Thursday, November 21st. HC Wainwright analyst S. Ramakanth now anticipates that the company will earn ($0.19) per share for the quarter, down from their previous estimate of ($0.17). HC Wainwright currently has a "Buy" rating and a $5.50 price target on the stock. The consensus estimate for Quantum-Si's current full-year earnings is ($0.65) per share. HC Wainwright also issued estimates for Quantum-Si's Q3 2025 earnings at ($0.19) EPS, Q4 2025 earnings at ($0.19) EPS, FY2025 earnings at ($0.75) EPS, FY2026 earnings at ($0.69) EPS and FY2027 earnings at ($0.51) EPS.
Separately, Canaccord Genuity Group lowered their price target on Quantum-Si from $1.50 to $1.00 and set a "hold" rating on the stock in a report on Wednesday, November 13th.
Read Our Latest Analysis on Quantum-Si
Quantum-Si Stock Down 15.4 %
NASDAQ QSI traded down $0.25 during trading hours on Monday, hitting $1.37. The company had a trading volume of 28,398,512 shares, compared to its average volume of 2,258,725. Quantum-Si has a fifty-two week low of $0.61 and a fifty-two week high of $2.43. The business has a fifty day simple moving average of $0.88 and a 200-day simple moving average of $1.07. The firm has a market cap of $195.51 million, a P/E ratio of -2.14 and a beta of 2.89.
Hedge Funds Weigh In On Quantum-Si
Hedge funds and other institutional investors have recently modified their holdings of the stock. Jacobs Levy Equity Management Inc. acquired a new stake in Quantum-Si during the 1st quarter worth about $998,000. Geode Capital Management LLC lifted its position in Quantum-Si by 6.7% in the 3rd quarter. Geode Capital Management LLC now owns 2,316,921 shares of the company's stock worth $2,044,000 after buying an additional 145,091 shares in the last quarter. Barclays PLC increased its stake in shares of Quantum-Si by 210.5% in the third quarter. Barclays PLC now owns 196,826 shares of the company's stock worth $173,000 after acquiring an additional 133,438 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of Quantum-Si by 1.6% during the first quarter. Vanguard Group Inc. now owns 5,300,685 shares of the company's stock worth $10,442,000 after acquiring an additional 82,463 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new position in Quantum-Si in the third quarter valued at about $53,000. Institutional investors and hedge funds own 39.90% of the company's stock.
About Quantum-Si
(
Get Free Report)
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
See Also
Before you consider Quantum-Si, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum-Si wasn't on the list.
While Quantum-Si currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
